AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7851580 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose estrogen oral contraceptives (OC)
Number of subjects: 49
Study 7851580 — intervention group
Group type: COMPARATOR
Intervention: Control (non-users)
Number of subjects: 49
Study 1778190 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 0
Study 1778190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent therapy with transdermal glyceryl trinitrate
Number of subjects: 0
Study 1778190 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo transdermal patches
Number of subjects: 0
Study 6247910 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic granulocyte transfusions and oral nonabsorbable antibiotics (group 1)
Number of subjects: 38
Study 6247910 — intervention group
Group type: COMPARATOR
Intervention: Oral nonabsorbable antibiotics alone (group 2)
Number of subjects: 38
Study 31809198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) with blood flow occlusion via pneumatic cuff
Number of subjects: 12
Study 31809198 — intervention group
Group type: COMPARATOR
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) without blood flow occlusion
Number of subjects: 12
Study 31809198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) with blood flow occlusion
Number of subjects: 12
Study 31127163 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity resistance circuit training for 12 weeks
Number of subjects: 45
Study 31127163 — intervention group
Group type: COMPARATOR
Intervention: No exercise intervention (Control group)
Number of subjects: 45
Study 28320331 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT-HIP intervention (multi-component cognitive behavioural intervention)
Number of subjects: 165
Study 28320331 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 165
Study 26073456 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil patient-controlled analgesia (RPCA)
Number of subjects: 290
Study 26073456 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia (EA)
Number of subjects: 290
Study 23677858 — intervention group
Group type: EXPERIMENTAL
Intervention: itraconazole (100 mg)
Number of subjects: 10
Study 23677858 — intervention group
Group type: COMPARATOR
Intervention: rifampicin (450 mg/day for 6 days)
Number of subjects: 10
Study 23677858 — intervention group
Group type: COMPARATOR
Intervention: grapefruit juice (300 mL)
Number of subjects: 10
Study 23677858 — intervention group
Group type: COMPARATOR
Intervention: control (water)
Number of subjects: 10
Study 22590901 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 zygote transfer
Number of subjects: 254
Study 22590901 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 254
Study 19118875 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel therapy for 3 months
Number of subjects: 30
Study 19118875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17006963 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient health valuations
Number of subjects: 0
Study 17006963 — intervention group
Group type: COMPARATOR
Intervention: General population health valuations
Number of subjects: 0
Study 17006963 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for moderate varicose veins
Number of subjects: 0
Study 17006963 — intervention group
Group type: EXPERIMENTAL
Intervention: Elicitation technique
Number of subjects: 0
Study 15233777 — intervention group
Group type: EXPERIMENTAL
Intervention: Probing depth measurements
Number of subjects: 15
Study 15233777 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated measurement
Number of subjects: 15
Study 11326395 — intervention group
Group type: EXPERIMENTAL
Intervention: Think First for Kids (TFFK) intervention program
Number of subjects: 0
Study 11326395 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 9392555 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical simulation followed by port filming
Number of subjects: 75
Study 9392555 — intervention group
Group type: COMPARATOR
Intervention: No physical simulation, only port filming
Number of subjects: 75
Study 7910323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 111
Study 7910323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 3361980 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta 2-mimetics
Number of subjects: 0
Study 3361980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31522784 — intervention group
Group type: EXPERIMENTAL
Intervention: Teduglutide 0.05 mg/kg/day for 24 and 36 months
Number of subjects: 73
Study 31522784 — intervention group
Group type: EXPERIMENTAL
Intervention: Histology results for 7 patients
Number of subjects: 73
Study 30318065 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 150
Study 30318065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 28355708 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of Ginkgo biloba (Ginaton) 70 mg once a day for 2 weeks
Number of subjects: 84
Study 28355708 — intervention group
Group type: COMPARATOR
Intervention: Routine treatments of hyperbaric oxygen, cure cerebral edema, and promote brain cell metabolism
Number of subjects: 84
Study 26264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/severe pulmonary hypertension (mPAP ≥35 mm Hg)
Number of subjects: 2180
Study 26264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild pulmonary hypertension (mPAP <35 mm Hg)
Number of subjects: 2180
Study 26264371 — intervention group
Group type: EXPERIMENTAL
Intervention: None pulmonary hypertension (mPAP <35 mm Hg)
Number of subjects: 2180
Study 26264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical factors (oxygen-dependent lung disease, inability to perform a 6 min walk, impaired renal function, lower aortic valve mean gradient)
Number of subjects: 2180
Study 26264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score including clinical factors
Number of subjects: 2180
Study 23756273 — intervention group
Group type: EXPERIMENTAL
Intervention: Early staple removal (postoperative day 3)
Number of subjects: 295
Study 23756273 — intervention group
Group type: COMPARATOR
Intervention: Delayed staple removal (between postoperative day 7 and day 10)
Number of subjects: 295
Study 23756273 — intervention group
Group type: EXPERIMENTAL
Intervention: Early staple removal
Number of subjects: 295
Study 23756273 — intervention group
Group type: COMPARATOR
Intervention: Delayed staple removal
Number of subjects: 295
Study 20415638 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH 1.5 mg scqd + ART for 48 weeks (Arm A)
Number of subjects: 60
Study 20415638 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH 3.0 mg scqd + ART for 24 weeks (Arm B)
Number of subjects: 60
Study 20415638 — intervention group
Group type: COMPARATOR
Intervention: ART alone for 24 weeks then rhGH 3.0 mg scqd for 24 weeks (Arm B)
Number of subjects: 60
Study 18590757 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart-rate feedback with educational program (EG)
Number of subjects: 210
Study 18590757 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart-rate feedback without educational program (NEG)
Number of subjects: 210
Study 18590757 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 210
Study 16761010 — intervention group
Group type: EXPERIMENTAL
Intervention: Less rigid glucose management
Number of subjects: 22
Study 16761010 — intervention group
Group type: COMPARATOR
Intervention: Rigid glucose management
Number of subjects: 22
Study 14674814 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power men attentive to subordinate weaknesses in a masculine domain
Number of subjects: 0
Study 14674814 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power men attentive to subordinate strengths in a masculine domain
Number of subjects: 0
Study 10983669 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 164
Study 10983669 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 164
Study 9026181 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0
Study 9026181 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study 9026181 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 0
Study 9026181 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of drugs
Number of subjects: 0
Study 1335361 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg sumatriptan
Number of subjects: 36
Study 1335361 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg sumatriptan
Number of subjects: 36
Study 1335361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 6367368 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic beta‐receptor blockade with oxprenolol
Number of subjects: 22
Study 6367368 — intervention group
Group type: COMPARATOR
Intervention: Untreated essential hypertension of the low renin type
Number of subjects: 22
Study 31734568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral System of Psychotherapy (CBASP) for 48 weeks
Number of subjects: 237
Study 31734568 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy (SP) for 48 weeks
Number of subjects: 237
Study 30221438 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog-assisted therapy
Number of subjects: 31
Study 30221438 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dog-assisted therapy)
Number of subjects: 31
Study 28917154 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention (12-week duration)
Number of subjects: 55
Study 28917154 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 55
Study 28917154 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessment (n-back task during fMRI)
Number of subjects: 55
Study 28917154 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-stress rehabilitation
Number of subjects: 55
Study 25721184 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based interpersonal psychotherapy (FB-IPT)
Number of subjects: 42
Study 25721184 — intervention group
Group type: COMPARATOR
Intervention: Child-centered therapy (CCT)
Number of subjects: 42
Study 23968458 — intervention group
Group type: EXPERIMENTAL
Intervention: Faustlos (violence prevention program)
Number of subjects: 5300
Study 23968458 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Steps (psychoanalytically based intervention)
Number of subjects: 5300
Study 21376917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-As-You-Drive insurance fee
Number of subjects: 0
Study 21376917 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 19778661 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk estimation systems
Number of subjects: 0
Study 19778661 — intervention group
Group type: EXPERIMENTAL
Intervention: New risk factors
Number of subjects: 0
Study 19778661 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple risk estimation approach
Number of subjects: 0
Study 17727813 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed sensory description of the cold-pressor task (cold-pressor arm immersion in 10 degrees C water) with imagery-based distraction intervention.
Number of subjects: 78
Study 17727813 — intervention group
Group type: COMPARATOR
Intervention: Detailed sensory description of the cold-pressor task (cold-pressor arm immersion in 10 degrees C water) without distraction.
Number of subjects: 78
Study 17727813 — intervention group
Group type: EXPERIMENTAL
Intervention: Control instructions lacking sensory information with imagery-based distraction intervention.
Number of subjects: 78
Study 17727813 — intervention group
Group type: COMPARATOR
Intervention: Control instructions lacking sensory information without distraction.
Number of subjects: 78
Study 15592552 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial caries removal followed by lining with black copper cement (BCC) and restoration with glass ionomer cement (GIC) (PCR:BCC)
Number of subjects: 44
Study 15592552 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial caries removal and restoration with GIC alone (PCR:GIC)
Number of subjects: 44
Study 15592552 — intervention group
Group type: COMPARATOR
Intervention: Complete caries removal and conventional restoration (CR)
Number of subjects: 44
Study 11451599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate Cream
Number of subjects: 85
Study 11451599 — intervention group
Group type: COMPARATOR
Intervention: Other topical antimicrobial agents
Number of subjects: 85
Study 11451599 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 85
Study 9751681 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber atrial pacing (110 patients)
Number of subjects: 225
Study 9751681 — intervention group
Group type: COMPARATOR
Intervention: Single-chamber ventricular pacing (115 patients)
Number of subjects: 225
Study 8141172 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe sodium restriction (20 mmol Na/d)
Number of subjects: 163
Study 8141172 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate sodium restriction (85 mmol Na/d)
Number of subjects: 163
Study 8141172 — intervention group
Group type: COMPARATOR
Intervention: High sodium diet (300 mmol Na/d)
Number of subjects: 163
Study 8141172 — intervention group
Group type: COMPARATOR
Intervention: Normal sodium diet (200 mmol Na/d)
Number of subjects: 163
Study 3061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 0.185 mg/kg
Number of subjects: 22
Study 3061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 0.270 mg/kg
Number of subjects: 22
Study 3061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 0.400 mg/kg
Number of subjects: 22
Study 3061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol (all doses)
Number of subjects: 22
Study 3061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective measurements of tremor
Number of subjects: 22
Study 30160543 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm Olein (POL)
Number of subjects: 67
Study 30160543 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa Butter (CB)
Number of subjects: 67
Study 30160543 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil (EVOO)
Number of subjects: 67
Study 28649780 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TXA 250 mg twice daily
Number of subjects: 100
Study 28649780 — intervention group
Group type: COMPARATOR
Intervention: Intraderma microinjections of TXA 4 mg/mL every 4 weeks
Number of subjects: 100
Study 25958319 — intervention group
Group type: EXPERIMENTAL
Intervention: IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin (TAP regimen)
Number of subjects: 21
Study 23074995 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative cervical collar usage (n = 17)
Number of subjects: 33
Study 23074995 — intervention group
Group type: COMPARATOR
Intervention: No post-operative cervical collar usage (n = 16)
Number of subjects: 33
Study 21292895 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral miltefosine (2.5 mg/kg/day for 28 days)
Number of subjects: 90
Study 21292895 — intervention group
Group type: COMPARATOR
Intervention: Parenteral antimony (15-20 mg/Sb/kg/day for 20 days)
Number of subjects: 90
Study 16527863 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling frequency at 60 r.p.m.
Number of subjects: 11
Study 16527863 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling frequency at 100 r.p.m.
Number of subjects: 11
Study 16527863 — intervention group
Group type: COMPARATOR
Intervention: Cross-country runners (END) at both pedal frequencies.
Number of subjects: 11
Study 16527863 — intervention group
Group type: COMPARATOR
Intervention: Sprinters (SPR) at both pedal frequencies.
Number of subjects: 11
Study 14503832 — intervention group
Group type: EXPERIMENTAL
Intervention: ISO standards
Number of subjects: 30
Study 14503832 — intervention group
Group type: COMPARATOR
Intervention: Root-dipping technique
Number of subjects: 30
Study 10965516 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt treatment (2 cups, 454 g/day) for three months
Number of subjects: 25
Study 10965516 — intervention group
Group type: COMPARATOR
Intervention: Control (no yogurt consumption for three months)
Number of subjects: 25
Study 9069134 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 50
Study 9069134 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 50
Study 8450576 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapies for cocaine abuse (specifics not provided)
Number of subjects: 0
Study 2980616 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 1377
Study 2980616 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1377
Study 30439971 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centered and integrated-care service (Embrace)
Number of subjects: 11
Study 26928838 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Cholera Vaccine (OCV)
Number of subjects: 388
Study 26928838 — intervention group
Group type: COMPARATOR
Intervention: Control (Unvaccinated)
Number of subjects: 388
Study 24071820 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine lidocaine
Number of subjects: 120
Study 24071820 — intervention group
Group type: COMPARATOR
Intervention: Paracervical block
Number of subjects: 120
Study 22323710 — intervention group
Group type: EXPERIMENTAL
Intervention: Weightlessness condition during parabolic flight
Number of subjects: 0
Study 22323710 — intervention group
Group type: COMPARATOR
Intervention: Ground trials
Number of subjects: 0
Study 20361924 — intervention group
Group type: COMPARATOR
Intervention: Almond skin polyphenols
Number of subjects: 0
Study 18415764 — intervention group
Group type: EXPERIMENTAL
Intervention: Three disease-modifying anti-rheumatic drugs (DMARDs) and low-dose prednisolone (COMBI)
Number of subjects: 182
Study 18415764 — intervention group
Group type: COMPARATOR
Intervention: Single DMARD with or without low-dose prednisolone (SINGLE)
Number of subjects: 182
Study 15660084 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse on the day of surgery only
Number of subjects: 7
Study 15660084 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse on the day of surgery and several days after
Number of subjects: 7
Study 12028323 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan doses of 2.5 to 40 mg
Number of subjects: 1453
Study 12028323 — intervention group
Group type: COMPARATOR
Intervention: Frovatriptan doses of 0.5 mg and 1 mg
Number of subjects: 1453
Study 12028323 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan dose of 2.5 mg
Number of subjects: 1453
Study 12028323 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan doses above 2.5 mg
Number of subjects: 1453
Study 12028323 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan doses of 10 mg and above
Number of subjects: 1453
Study 10726234 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg for 1 week
Number of subjects: 22
Study 10726234 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg for 3 weeks
Number of subjects: 22
Study 10726234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 8784216 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 0
Study 2264710 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil (300 to 500 mg/day)
Number of subjects: 227
Study 2264710 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (180 to 300 mg/day)
Number of subjects: 227
Study 442947 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 28
Study 30767047 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray
Number of subjects: 82
Study 30767047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial expressions not previously theorized to signal any emotion
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Three different facial expressions
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototypical sad expression
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototypical fear expression
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial expression labeled with a made-up word (tolen)
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Context focused on demonstrating a process of elimination
Number of subjects: 1068
Study 27893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly used method with 4 target expressions
Number of subjects: 1068
Study 26674992 — intervention group
Group type: EXPERIMENTAL
Intervention: faith-based lifestyle intervention
Number of subjects: 373
Study 26674992 — intervention group
Group type: COMPARATOR
Intervention: health education control
Number of subjects: 373
Study 23524367 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 seconds stretching
Number of subjects: 24
Study 23524367 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 seconds stretching
Number of subjects: 24
Study 23524367 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 seconds stretching
Number of subjects: 24
Study 23524367 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 seconds stretching
Number of subjects: 24
Study 23524367 — intervention group
Group type: EXPERIMENTAL
Intervention: All stretching durations
Number of subjects: 24
Study 21293304 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg · kg(‐1))
Number of subjects: 14
Study 21293304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 21293304 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 14